ASIF News

Apr 17, 2018
ASIF 13th General Council Meeting

Walk AS One would like to invite all ASIF members to join the 7th annual awareness and advocacy campaign, Walk Your A.S. Off,

Read More
Apr 18, 2018
ASIF Scientific Advisor

We are pleased to announce the appointment of ASIF's new Scientific Adviser. Dr Uta Kiltz is the Senior Rheumatologist at

Read More
Apr 30, 2018
ASIF 13th General Council Meeting

Guangzhou, China 10-13 October 2018 The ASIF Council meeting will take place in China this year, kindly

Read More
Apr 30, 2018
ASIF Represented at ACR 2017

In November, 2017, we were represented at the American College of Rheumatology Annual Meeting in San Diego, California, by AS

Read More
Apr 30, 2018
New CEO at NASS, the UK’s National Ankylosing Spondylitis Society

Dr. Dale Webb joined NASS as CEO in early November. He brings 25 years’ experience of working in health-related areas - hav

Read More
Apr 30, 2018
New CEO at the Spondylitis Association of America (SAA)

Cassie Shafer joined the Spondylitis Association of America (SAA) as the new CEO in late September 2017. Cassie brings with

Read More
Apr 30, 2018
Changes at the Canadian Spondylitis Association

The Canadian Spondylitis Association underwent many changes in 2017. In June, Michael Mallinson retired as president of the C

Read More
Apr 30, 2018
Sculpture Exhibition “Disease of Young People or Life with Pain” in Moscow

From 4 to 13 December, the Ankylosing Spondylitis Association of the Russian Federation created a sculpture exhibition in Mos

Read More
Apr 30, 2018
UCB’s CIMZIA© approved for potential use in women with AS during breastfeeding and pregnancy

The European Medicines Agency (EMA) has approved the label change for UCB's CIMZIA© (certolizumab pegol), making it the firs

Read More
Apr 30, 2018
Intimacy and AS

Michael Mallinson has lived with AS for over 35 years. He developed this content as a consultant to Novartis Pharmaceutic

Read More